What the Latest Research Reveals About THCA’s Potential in Cancer Treatment
With increasing interest in cannabis as a therapeutic agent, THCA has
emerged as a candidate for cancer treatment. THCA has no psychoactive effects
and unlike its metabolite THC, seems to possess different health benefits. This
blog looks at what the current body of research suggests about the use of THCA
Flowers in the treatment of cancer. How it works, and what limitations
researchers encounter at this time.
What is THCA?
THCA is a cannabinoid present in fresh cannabis plants and has not been
synthesized yet. What stands out when using CBD is that it overcomes the
psychoactive effect. Since it has not undergone decarboxylation a process that
activates this compound. THCA is THC when cannabis is heated or aged so that
the acids are reduced to plain THC. THCA has recently stirred interest because
of its non-psychoactive benefits without the heinous side effects to its users.
The Mechanisms of
THCA: How Might It Help Fight Cancer?
Treatment of cancer is not a one-standard process and may embrace
different therapeutic processes; hence, it can interface several of THCA. While
science is limited with regards to the product, it indicates that THCA binds
with the body’s endocannabinoid system (ECS) that manages events like
inflammation, the immune system, cell division etc. ECS has CB1 and CB2
receptors can have promoting or inhibitory effects for tumor depending on the
activation.
1. Anti-Inflammatory Effects
Since inflammation is known to play a role in tumour initiation and
promotion. Thus, studying agents that reduce inflammation is important. The
Maryland team found out that chronic inflammation affects DNA. It encourages
the formation of abnormal cells and even promotes the development of a tumour.
Studied effects of THCA
Flower indicate that this compound may possess an anti-inflammatory
action due to suppression of the activity of pro-inflammatory enzymes and
cytokines. A study conducted in 2020 by Bhattacharyya et al in Scientific
Reports establishes that, when used with other cannabinoids, THCA is useful in
the suppression of inflammation in all the tested models.
2. Anti-Proliferative Properties
THCA has been known to give some enforcement on cancer cell
proliferation. Also referred to as the process of growth of cells many times as
a result of damage forming tumors. THCA as a result of previous laboratory
studies has been shown to inhibit growth of some types of cancer cells. In 2017
a study of the effect of THCA for glioblastoma, an aggressive type of brain
cancer, suggested that it somehow decreases the rate of growth of these cells
through its effect on cell cycle. These findings are refreshing albeit
preclinical studies therefore, more research is required.
3. Apoptosis Induction
The process of apoptosis is important in eliminating the threat of
cancer cells spreading with the assistance of other cells. In some of the
cancers, there is somehow a disturbance in the normal process of apoptosis.
Resulting in extension of lifespan of such unwanted cells. Proof from
exploratory research shows that THCA
Flower has potential to encourage the cancer cells to undergo
apoptosis. For instance, a journal in Frontiers in Pharmacology showed that
THCA caused apoptosis in breast cancer cell cultures. Although it has not yet
been well established in people.
4. Interaction with CB1 and CB2 Receptors
The CB1 and CB2 receptors belonging to ECS are particularly engaged by
cannabinoids. THCA, for that reason, seems to have a weak binding affinity
toward these receptors. Thus, these suggests that it could operate through
different channels or indirectly act on the ECS. This novel system indicates
that THCA may present another approach to oncology which may decrease general
tumour formation. Along with decreasing some of the potential side effects
connected with high-THC medicines. Data is being collected as to how THCA may
trigger these receptors in a way that THC or other cannabinoids may not, with
implications to cancer prognosis.
Current Research:
What Are the Findings?
Studies in Animal Models
Much of the research on THCA in cancer treatment is in animal models,
specifically mice. For example, a cross-sectional study of a mouse model of
colorectal cancer published in 2019, concluded that THCA Flower showed promising
results. Including decrease in size and metastatic activity of the tumours. It
was possible to conclude that THCA could have action leading to decrease of
tumor invasiveness. And therefore, lead to better survival rates. However,
those findings based on animal studies are usually in the first place and can
give various results in human studies.
Cell Line Studies
Cancer cell line investigations are employed to provide initial data
before case investigations. A paper done in 2021 specifically on prostate
cancer cell lines showed that THCA suppressed cell division and caused cell
death. Lung cancer cells were also targeted in another study. Where it was
found that THCA reduced cell proliferation but high doses could mean a
difference impact. These studies are, however, encouraging and reveal that the
efficacy of THCA Flower is not so simple when it comes to the impact on various
types of cancer cells.
Human Studies
Surprisingly, there are not many human trials when it comes to THCA.
Cancer patients as a group seem to stand to gain from THCA. However, as stated
above, evidence is still largely anecdotal. Challenges posed by regulation plus
the psychoactive effects of cannabis means that it has been hard for
researchers to conduct human trials of THCA for cancer treatment. However,
other cannabinoids are still under research to prove safety and efficiency for
cancer patients.
THCA Flower Benefits
in Symptom Management for Cancer Patients
Besides the direct effect on cancer cells, THCA Flower might have several advantages when it comes to
cancer symptoms and side effects of treatment.
1. Pain Relief
Cancer patients will always complain of pain as they undergo treatment
such as chemotherapy that is invasive in nature. Research suggests that THCA
Flower may have pain relief potential. Primarily through its anti-inflammatory
effects and agonism at the ECS. While not as effective as THC in managing pain.
THCA Flower may be ideal for anyone in need of a pain reliever with no
hallucinogenic effects.
2. Anti-Nausea and Appetite Stimulation
THCA is also explored also for its effectiveness in the treatment of side
effects of cancer treatments such as nausea and loss of appetite. A study
conducted on rats in the Psychopharmacology journal argues that while THCA was
superior to THC in alleviating nausea. It is still in its infancy in human
study. However, this points to the potential of THCA being a better option for
patients who wish to avoid the potency of THC.
3. Improved Sleep
Patients with cancer suffer from either poor sleep quality or insomnia.
Such complications are usually as a consequence of pain, stress or
complications resulting from treatments. Before giving the prognosis it should
be noted that primary research shows positive results in the sphere of the
influence of THCA Flower on
improving the quality of sleep. But here also the effectiveness largely may
depend on the dosage试 and individual sensitivity of the patient.
Challenges and
Limitations of THCA in Cancer Treatment
The major cons of using THCA in cancer treatment are as followsилась
1. Limited Research and Funding
Compared with other forms of the cannabinoids such as CBD, there is
limited data available on the use of THCA in cancer treatment. This makes it
difficult to establish conclusive findings on its efficacy as a cancer
treatment option. Research conducted on THCA is somewhat scarce. Which in large
part due to legal and funding constraints. Most of the data obtained here are
preclinical and not clinical. This means that the evidence on the effects and
safety of THCA in cancer patients is limited.
2. Lack of Standardized Dosing
One of the main problematic issues concerning THCA research is The lack
of standardized dosing. Most relevant evidence lacks detailed description of
dose targets. Which may lead to a lack of clear recommendations on the use of
THCA for health care providers and patients. Further, the stability of THCA is
an issue. Because it can be degrading to THC when exposed to heat, light and
improper storage condition.
3. Potential Drug Interactions
A condition that most cancer patients develop will be on the use of
multiple medicines. Whereby the medicines will cause an interaction with THCA.
For instance, many argue that THCA may interfere with the enzymes acting on
drugs thus changing the efficacy of a particular drug. Further study of these
interactions is required to develop recommendations for safe THCA utilization
for cancer patients.
What’s Next for THCA
in Cancer Research?
There are positive but inconclusive results. It may be concluded that
THCA research in cancer treatment seems to have reached a crucial point. Higher
demand from medical practitioners and patient organizations may play a role to
bring more human trials in the next few years. Scientists now plan to deepen
our understanding of how THCA affects the cancer cells. And the endocannabinoid
system to develop new types of cancer treatment that will not pose the same
number of side effects as present cancer treatments do.
Final Word
THCA may be helpful for symptom relief and is considered as adjuvant
therapy in cancer. However, the current study, as most publishing today, is
mostly of a preclinical nature. Although THCA
Flower displays ant-inflammatory, ant-proliferative and apoptosis effects
in cell and animal research. Still, large-scale human controlled clinical
trials are required to evaluate its efficacy and side effects.
However, for the patients who wish to try THCA, it is mandatory to
involve the medical practitioners. All the presented results imply that THCA as
an emerging treatment presents not only a promising choice, but its
applicability in cancer therapy remains uncertain due to the lack of solid
data. In the meantime, THCA can be considered a promising direction within the
large field of cannabinoids to change the quality of human life and potentially
COCA therapeutic effects for cancer.
Comments